DOCETAXEL INDUCED PNEUMONITIS IN PATIENTS WITH METASTATIC PROSTATE CANCER

被引：0
|
作者：
Arasaratnam, Malmaruha [1 ]
Crumbaker, Megan [2 ]
Boys, Emma L. [1 ]
Gao, Bo [1 ]
Gurney, Howard [1 ,3 ]
机构：
[1] Westmead Hosp, Crown Princess Mary Canc Ctr, Med Oncol, Sydney, NSW, Australia
[2] Kinghord Canc Ctr, Med Oncol, Sydney, NSW, Australia
[3] Macquarie Univ, Med Oncol, Sydney, NSW, Australia
来源：
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
100
引用
收藏
页码：40 / 40
页数：1
相关论文
共 50 条
  • [21] A phase I study of docetaxel plus synthetic lycopene in metastatic prostate cancer patients
    Lilly, Michael B.
    Wu, Chunli
    Ke, Yu
    Chen, Wen-Pin
    Soloff, Adam C.
    Armeson, Kent
    Yokoyama, Noriko N.
    Li, Xiaotian
    Song, Liankun
    Yuan, Ying
    McLaren, Christine E.
    Zi, Xiaolin
    CLINICAL AND TRANSLATIONAL MEDICINE, 2024, 14 (03):
  • [22] Docetaxel and cisplatin in patients with metastatic androgen independent prostate cancer and circulating neuroendocrine markers
    Culine, Stephane
    El Demery, Mounira
    Lamy, Pierre-Jean
    Iborra, Francois
    Avances, Christophe
    Pinguet, Frederic
    JOURNAL OF UROLOGY, 2007, 178 (03): : 844 - 848
  • [23] Body composition as a predictor of chemotherapy toxicity in patients with metastatic prostate cancer treated with docetaxel
    Cushen, S. J.
    Power, D. G.
    McDermot, R.
    O'Sullivan, K.
    Maceneaney, P.
    Daly, L.
    Ryan, A. M.
    PROCEEDINGS OF THE NUTRITION SOCIETY, 2015, 74 (OCE2) : E165 - E165
  • [24] Docetaxel, estramustine, plus trastuzumab in patients with metastatic androgen-independent prostate cancer
    Small, EJ
    Bok, R
    Reese, DM
    Sudilovsky, D
    Frohlich, M
    SEMINARS IN ONCOLOGY, 2001, 28 (04) : 71 - 76
  • [25] Docetaxel reintroduction in patients with metastatic castration-resistant docetaxel-sensitive prostate cancer: a retrospective multicentre study
    Eymard, Jean-Christophe
    Oudard, Stephane
    Gravis, Gwenaelle
    Ferrero, Jean-Marc
    Theodore, Christine
    Joly, Florence
    Priou, Frank
    Krakowski, Ivan
    Zannetti, Alain
    Thill, Laurence
    Beuzeboc, Philippe
    BJU INTERNATIONAL, 2010, 106 (07) : 974 - 978
  • [26] Metastatic prostate cancer: what's new since docetaxel?
    Gross-Goupil, M.
    Fizazi, K.
    ONCOLOGIE, 2008, 10 (11) : 648 - 652
  • [27] Metastatic castration-sensitive prostate cancer: Abiraterone, docetaxel, or ...
    Barata, Pedro C.
    Sartor, A. Oliver
    CANCER, 2019, 125 (11) : 1777 - 1788
  • [28] Androgens and Overall Survival in Patients With Metastatic Castration-resistant Prostate Cancer Treated With Docetaxel
    Ryan, Charles J.
    Dutta, Sandipan
    Kelly, William K.
    Middleberg, Rob
    Russell, Carly
    Morris, Michael J.
    Taplin, Mary-Ellen
    Halabi, Susan
    CLINICAL GENITOURINARY CANCER, 2020, 18 (03) : 222 - +
  • [29] Diethylstilbestrol and docetaxel: A phase II study in patients with metastatic, androgen independent prostate cancer.
    Montgomery, B.
    Lin, D.
    Ryan, C.
    Garzotto, M.
    Beer, T. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 248S - 248S
  • [30] DOSE-FINDING WEEKLY DOCETAXEL PLUS ESTRAMUSTINE IN PATIENTS WITH HORMONORESISTANT METASTATIC PROSTATE CANCER
    Coccaro, M.
    Romano, G.
    Tartarone, A.
    Iodice, G.
    Bochicchio, A. M.
    Di Leo, P.
    Vigliotti, M. L.
    Mele, G.
    Musto, C.
    Di Renzo, N.
    ANNALS OF ONCOLOGY, 2004, 15 : 96 - 96
12345